These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34335977)

  • 1. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19.
    Wang C; Li X; Ning W; Gong S; Yang F; Fang C; Gong Y; Wu D; Huang M; Gou Y; Fu S; Ren Y; Yang R; Qiu Y; Xue Y; Xu Y; Zhou X
    Theranostics; 2021; 11(16):8008-8026. PubMed ID: 34335977
    [No Abstract]   [Full Text] [Related]  

  • 2. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
    Gisby J; Clarke CL; Medjeral-Thomas N; Malik TH; Papadaki A; Mortimer PM; Buang NB; Lewis S; Pereira M; Toulza F; Fagnano E; Mawhin MA; Dutton EE; Tapeng L; Richard AC; Kirk PD; Behmoaras J; Sandhu E; McAdoo SP; Prendecki MF; Pickering MC; Botto M; Willicombe M; Thomas DC; Peters JE
    Elife; 2021 Mar; 10():. PubMed ID: 33704068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
    Elgedawy GA; Samir M; Elabd NS; Elsaid HH; Enar M; Salem RH; Montaser BA; AboShabaan HS; Seddik RM; El-Askaeri SM; Omar MM; Helal ML
    PLoS One; 2024; 19(5):e0302977. PubMed ID: 38814977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics study of COVID-19 patients in four different clinical stages.
    Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
    Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
    Wilk AJ; Lee MJ; Wei B; Parks B; Pi R; Martínez-Colón GJ; Ranganath T; Zhao NQ; Taylor S; Becker W; ; Jimenez-Morales D; Blomkalns AL; O'Hara R; Ashley EA; Nadeau KC; Yang S; Holmes S; Rabinovitch M; Rogers AJ; Greenleaf WJ; Blish CA
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
    Shu T; Ning W; Wu D; Xu J; Han Q; Huang M; Zou X; Yang Q; Yuan Y; Bie Y; Pan S; Mu J; Han Y; Yang X; Zhou H; Li R; Ren Y; Chen X; Yao S; Qiu Y; Zhang DY; Xue Y; Shang Y; Zhou X
    Immunity; 2020 Nov; 53(5):1108-1122.e5. PubMed ID: 33128875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.
    Bi X; Liu W; Ding X; Liang S; Zheng Y; Zhu X; Quan S; Yi X; Xiang N; Du J; Lyu H; Yu D; Zhang C; Xu L; Ge W; Zhan X; He J; Xiong Z; Zhang S; Li Y; Xu P; Zhu G; Wang D; Zhu H; Chen S; Li J; Zhao H; Zhu Y; Liu H; Xu J; Shen B; Guo T
    Cell Rep; 2022 Jan; 38(3):110271. PubMed ID: 35026155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage.
    Chen YM; Zheng Y; Yu Y; Wang Y; Huang Q; Qian F; Sun L; Song ZG; Chen Z; Feng J; An Y; Yang J; Su Z; Sun S; Dai F; Chen Q; Lu Q; Li P; Ling Y; Yang Z; Tang H; Shi L; Jin L; Holmes EC; Ding C; Zhu TY; Zhang YZ
    EMBO J; 2020 Dec; 39(24):e105896. PubMed ID: 33140861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
    Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S
    J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective view of pediatric cases infected with SARS-CoV-2 of a middle-sized city in mainland China.
    Kang Y; You Z; Wang K; Dong Z; Zhang J; Qiu Y; Ge G
    Medicine (Baltimore); 2020 Dec; 99(51):e23797. PubMed ID: 33371153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
    Lodge S; Nitschke P; Kimhofer T; Coudert JD; Begum S; Bong SH; Richards T; Edgar D; Raby E; Spraul M; Schaefer H; Lindon JC; Loo RL; Holmes E; Nicholson JK
    J Proteome Res; 2021 Feb; 20(2):1382-1396. PubMed ID: 33426894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
    Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge.
    Li H; Li X; Wu Q; Wang X; Qin Z; Wang Y; He Y; Wu Q; Li L; Chen H
    Cell Death Dis; 2022 Mar; 13(3):235. PubMed ID: 35288537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients.
    Yang Z; Wu D; Lu S; Qiu Y; Hua Z; Tan F; Zhang C; Zhang L; Zhang DY; Zhou X; Cai Z; Shang Y; Lin SH
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2117089119. PubMed ID: 35943976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
    Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
    Ma Q; Xie Y; Wang Z; Lei B; Chen R; Liu B; Jiang H; Wang Y; Liu Q; Yang Z
    J Ethnopharmacol; 2021 Oct; 279():114367. PubMed ID: 34174375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.